Zobrazeno 1 - 10
of 56
pro vyhledávání: '"HLA ligandome"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Angel Charles, Christopher M. Bourne, Tanya Korontsvit, Zita E. H. Aretz, Sung Soo Mun, Tao Dao, Martin G. Klatt, David A. Scheinberg
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Cyclin dependent kinase 4/6 inhibitors (CDK4/6i) lead to cell-cycle arrest but also trigger T cell-mediated immunity, which might be mediated by changes in human leukocyte antigen (HLA) ligands. We investigated the effects of CDK4/6i, abemaciclib and
Externí odkaz:
https://doaj.org/article/a3a63b8e735c4265b023dcb79db8e5ba
Autor:
Tomoyo Shinkawa, Serina Tokita, Munehide Nakatsugawa, Yasuhiro Kikuchi, Takayuki Kanaseki, Toshihiko Torigoe
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
CD8+ T cells are capable of recognizing mutation-derived neoantigens displayed by HLA class I molecules, thereby exhibiting the ability to distinguish between cancer and normal cells. However, accumulating evidence has shown that only a small fractio
Externí odkaz:
https://doaj.org/article/cd207c8fc7084b698ed44490a7e0fda9
Autor:
Markus W. Löffler, Bianca Nussbaum, Günter Jäger, Philipp S. Jurmeister, Jan Budczies, Philippe L. Pereira, Stephan Clasen, Daniel J. Kowalewski, Lena Mühlenbruch, Ingmar Königsrainer, Stefan Beckert, Ruth Ladurner, Silvia Wagner, Florian Bullinger, Thorben H. Gross, Christopher Schroeder, Bence Sipos, Alfred Königsrainer, Stefan Stevanović, Carsten Denkert, Hans-Georg Rammensee, Cécile Gouttefangeas, Sebastian P. Haen
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Radiofrequency ablation (RFA) is an established treatment option for malignancies located in the liver. RFA-induced irreversible coagulation necrosis leads to the release of danger signals and cellular content. Hence, RFA may constitute a
Externí odkaz:
https://doaj.org/article/74056cdd032845e8b54ae982cf9f4f25
Autor:
Vitaly Kochin, Takayuki Kanaseki, Serina Tokita, Sho Miyamoto, Yosuke Shionoya, Yasuhiro Kikuchi, Daichi Morooka, Yoshihiko Hirohashi, Tomohide Tsukahara, Kazue Watanabe, Shingo Toji, Yasuo Kokai, Noriyuki Sato, Toshihiko Torigoe
Publikováno v:
OncoImmunology, Vol 6, Iss 4 (2017)
This study focused on HLA-A24 and comprehensively analyzed the ligandome of colon and lung cancer cells without the use of MHC-binding in silico prediction algorithms. Affinity purification using the antibody specific to HLA-A24 followed by LC–MS/M
Externí odkaz:
https://doaj.org/article/7afea113c05647e4a474bb5700a217f7
Autor:
Annika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, Heiko Schuster, Olaf-Oliver Wolz, Janet Kerstin Peper, Yamel Cardona Gloria, Anton W. Langerak, Alice F. Muggen, Rainer Claus, Irina Bonzheim, Falko Fend, Helmut Rainer Salih, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanović, Alexander N. R. Weber
Publikováno v:
OncoImmunology, Vol 6, Iss 3 (2017)
Genome sequencing has uncovered an array of recurring somatic mutations in different non-Hodgkin lymphoma (NHL) subtypes. If affecting protein-coding regions, such mutations may yield mutation-derived peptides that may be presented by HLA class I pro
Externí odkaz:
https://doaj.org/article/6fbd23161b974b24849417e491c35159
Autor:
Sturm, Theo, Sautter, Benedikt, Wörner, Tobias P, Stevanović, Stefan, Rammensee, Hans-Georg, Planz, Oliver, Heck, Albert J R, Aebersold, Ruedi, Afd Biomol.Mass Spect. and Proteomics, Sub Biomol.Mass Spectrometry & Proteom., Biomolecular Mass Spectrometry and Proteomics
Publikováno v:
Journal of Proteome Research
Journal of Proteome Research, 20 (1)
Journal of Proteome Research, 20(1), 289. American Chemical Society
Journal of Proteome Research, 20 (1)
Journal of Proteome Research, 20(1), 289. American Chemical Society
To understand and treat immunology-related diseases, a comprehensive, unbiased characterization of major histocompatibility complex (MHC) peptide ligands is of key importance. Preceding the analysis by mass spectrometry, MHC class I peptide ligands a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f4e4bdba49edd14c09a2661ace6531
https://doi.org/10.1021/acs.jproteome.0c00386
https://doi.org/10.1021/acs.jproteome.0c00386
Autor:
Pankaj Kumar, Caitlin Boyne, Sydney Brown, Ayesha Qureshi, Peter Thorpe, Silvia A. Synowsky, Sally Shirran, Simon J. Powis
Publikováno v:
ImmunologyREFERENCES. 166(2)
Funding: Breast Cancer Now (Grant Number(s): 2018JulPR1086), Wellcome Trust (GrantNumber(s): 105621/Z/14/Z), Melville Charitable Trust. The recent success of monoclonal antibody checkpoint inhibitor therapies that enhance the ability of CD8+ T cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20997311ceb8f4f71a4b11c0cf7a794f
https://pubmed.ncbi.nlm.nih.gov/35318648
https://pubmed.ncbi.nlm.nih.gov/35318648
Autor:
Tomoyo, Shinkawa, Serina, Tokita, Munehide, Nakatsugawa, Yasuhiro, Kikuchi, Takayuki, Kanaseki, Toshihiko, Torigoe
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
CD8+ T cells are capable of recognizing mutation-derived neoantigens displayed by HLA class I molecules, thereby exhibiting the ability to distinguish between cancer and normal cells. However, accumulating evidence has shown that only a small fractio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a55e3cd3b27ca8d84483597c2af4356a
https://pubmed.ncbi.nlm.nih.gov/33537174
https://pubmed.ncbi.nlm.nih.gov/33537174
Autor:
Toshihiko Torigoe, Takayuki Kanaseki, Munehide Nakatsugawa, Tomoyo Shinkawa, Yasuhiro Kikuchi, Serina Tokita
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
CD8+ T cells are capable of recognizing mutation-derived neoantigens displayed by HLA class I molecules, thereby exhibiting the ability to distinguish between cancer and normal cells. However, accumulating evidence has shown that only a small fractio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd7c12b4bff37e02d343a10e1e94ad5
https://doaj.org/article/cd207c8fc7084b698ed44490a7e0fda9
https://doaj.org/article/cd207c8fc7084b698ed44490a7e0fda9